Dr. Mark Popovsky serves as Vice President and Chief Medical Officer of Haemonetics Corporation. He is on the editorial board of five journals and has held positions on numerous AABB, national and international committees, and NIH panels. Dr. Popovsky served in Nigeria in 2004 as a member of the PEPFAR delegation to that country. He is the recipient of numerous awards for contributions to transfusion medicine and teaching. Dr. Popovsky was the 2009 AABB Emily Cooley Awardee.
Dr. Popovsky is an honors graduate of the University of Vermont College of Medicine. He received his training in anatomic and clinical pathology at the National Institutes of Health, and in transfusion medicine at the Mayo Clinic. He served as Director of the Transfusion & Intravenous Services at the Mayo Clinic from 1982-1985. In 1985, Dr. Popovsky assumed the role of Medical Director of the American Red Cross – New England Region, a position he held until 1995. From 1996-2000, he was Chief Executive Officer & Chief Medical Officer of the New England Region.
He is an Adjunct Clinical Professor of Laboratory Medicine at Boston University Medical School and Associate Clinical Professor of Pathology at Harvard Medical School and Beth Israel Deaconess Medical Center in Boston. Dr. Popovsky has authored, or co-authored, over 375 publications in transfusion medicine and pathology. He is the editor and co-editor, respectively, of two reference books on transfusion medicine.
Dr. Robert Thurer serves as the Medical Director of Blood Management Solutions for Haemonetics Corporation. He is a graduate of Harvard Medical School and trained in general and cardiothoracic surgery at the Massachusetts General Hospital in Boston. Dr. Thurer completed additional training at the Southampton Western Chest Hospital in England, Children’s Hospital in Boston, and the Cleveland Clinic.
Dr. Thurer, a retired Associate Professor of Surgery at Harvard Medical School, practiced cardiothoracic surgery in Boston where he was Associate Chief of Thoracic Surgery and Head of the Thoracic Oncology Program at the Beth Israel Deaconess Medical Center. During this time the primary focus of his clinical research related to blood conservation and blood use in surgery. Among his many leadership positions, Dr. Thurer served as Chair of the Transfusion Alternatives Committee of the AABB and the Transfusion Alliance. He was a founding board member of the Society for the Advancement of Blood Management and was also a representative of the American Association for Thoracic Surgery to the AABB.
Before joining Haemonetics, Dr. Thurer was the founding Chief Academic Officer of the Harvard Medical School Dubai Center Institute for Postgraduate Education and Research and Executive Director of the Dubai Harvard Foundation for Medical Research. He is also a recipient of the Daniel D. Federman Outstanding Clinical Educator Award from Harvard Medical School and serves on the Board of Overseers of Dartmouth Medical School and is a past president of its Alumni Council.
© 2012 • Haemonetics Corporation • 400 Wood Road • Braintree • MA • 02184